Category: Stock Market

CSL Ltd (ASX: CSL) has crashed 60% from its all-time high. It now trades at just 12 times forecast FY2026 earnings.

That is a multiple more commonly associated with slow-growth industrial companies than with the world’s second-largest plasma-derived therapies business.

For long-term investors looking to buy quality businesses at basement prices, this could be the opportunity of the decade.

Why CSL shares crashed

The selling has been brutal and perhaps partially overdone.

Three forces converged on CSL shares in 2025 and 2026.

First, the broader ASX healthcare sector was sold aggressively as investors rotated into resources and energy stocks during the Middle East conflict.

Second, CSL delivered a series of earnings downgrades as plasma collection volumes normalised more slowly than expected following the COVID-19 disruption, and China albumin pricing weakened.

Third, the appointment of interim CEO Gordon Naylor following Paul McKenzie’s departure created leadership uncertainty at perhaps the wrong moment.

Management cited weakness in China albumin pricing, with revenue down $200 million from market value decline.

What’s more, US immunoglobulin inventory normalisation is expected to have a $300 million impact as the primary revenue headwinds.
The company  also flagged approximately US$5 billion in additional non-cash pre-tax impairments to be recognised across FY2026 and FY2027, largely relating to the CSL Vifor acquisition.

Interim CEO Gordon Naylor said:

Our growth initiatives are working, but the financial benefits will take longer than previously anticipated to materialise.

The sell-off was so severe that insiders began buying CSL shares on market in May 2026, with interim CEO Gordon Naylor purchasing 1,100 shares as a direct signal of his confidence in the business at current prices.

The sell-off looks overdone

CSL is the world’s second-largest plasma-derived therapies company, with an irreplaceable position in a market that has taken decades to build.

The barriers to entry in plasma collection, fractionation, and biopharmaceutical manufacturing are among the highest of any industry.

No competitor has meaningfully eroded CSL’s market position in the past 30 years.

The issues that drove the earnings downgrades, (plasma collection normalisation and China pricing) are both temporary.

Furthermore, the gross profit margin at CSL Behring, the core plasma business, is on a clear recovery path. UBS expects the margin to recover toward pre-COVID levels of approximately 57% by FY2028, with the biggest improvement occurring in FY2026.

That margin recovery, combined with volume growth as plasma collection catches up, has created an earnings recovery trajectory over the next two to three years.

What the brokers are saying about CSL shares

The broker community has remained largely constructive through the selloff.

Morgans carries a buy rating on CSL shares with a price target of $293.83, noting the restructuring augments rather than masks the underlying business. The broker added that streamlining operations and cost savings could support double-digit earnings growth over the medium term.

Macquarie retained its outperform rating on CSL shares following the most recent guidance update.

On the more cautious side, Sanlam Private Wealth holds a hold rating. The broker noted that while CSL appears good value over the longer term, other stocks could potentially deliver faster returns in the short to medium term.

Foolish takeaway

CSL shares at 12 times forecast earnings is not something that comes along often.

The plasma collection recovery and margin improvement narrative is underway.

Insiders are buying and Morgans sees upside to $293.83.

For patient investors who can look past the near-term noise and focus on where CSL’s earnings will be in three years, the current entry point could prove to be one of the great buying opportunities this stock has ever offered.

The post CSL shares trade at just 12 times forecast earnings. Here’s why they could be the buy of the decade appeared first on The Motley Fool Australia.

More reading

• CSL shares: bargain or value trap?
• 6 ASX shares with 35% to 75% growth ahead of them: experts
• Top brokers name 3 ASX shares to buy next week
• Up 15% in a week, is it too late to buy rebounding CSL shares?
• The ASX shares I’d pick in a FIFA World Cup first eleven

Motley Fool contributor Mark Verhoeven has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL. The Motley Fool Australia has recommended CSL. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

I’m still positive on ASX tech shares over the long term.

The sector can be volatile, and expectations can shift quickly. But I think the best technology businesses are still finding ways to become more important to their customers.

With FY27 approaching, I would be looking for companies that are not just attached to a popular theme but are building products and infrastructure that customers actually rely on. Here are three I would buy.

WiseTech Global Ltd (ASX: WTC)

WiseTech is the first ASX tech share I would buy.

The company is best known for CargoWise, its software platform for the global logistics industry.

I think the interesting thing about WiseTech is that logistics is full of friction. Freight forwarders, customs brokers, carriers, warehouses, importers, exporters, and regulators all need information to move accurately across borders, systems, documents, and time zones.

That creates a natural role for specialist software. CargoWise helps customers manage more of that workflow in one place. The deeper it becomes inside a logistics business, the harder it can be to replace. That embedded position is what I like most.

I also think logistics software could become more valuable as global trade becomes more demanding. Customers want better visibility, faster document handling, fewer manual errors, and more automation. Artificial intelligence (AI) could help with parts of that over time, but the platform still needs deep industry knowledge, data, and customer workflows behind it.

WiseTech is not without risk. Expectations can be high, acquisitions need to be integrated well, and investors will keep a close eye on management execution. But I think the company has built a rare global software position from Australia.

Netwealth Group Ltd (ASX: NWL)

Wealth management platform provider Netwealth is another ASX tech share I would buy for FY27.

A good investment platform can sit at the centre of an advice business. It can help advisers manage portfolios, reporting, administration, managed accounts, tax information, and client workflows.

That may sound behind-the-scenes, but I think it is extremely important.

Advisers do not want clunky systems when client needs are becoming more detailed. Retirees may need income strategies, younger investors may want transparency, and families may have several layers of financial goals. Platforms that make advice practices more efficient can become very valuable.

Netwealth has built a strong position in that market. I like its brand, its independent platform model, and its ability to benefit as more money moves through modern wealth systems.

It may have been growing strongly over the last decade, but I think Netwealth still has a long runway if it keeps winning adviser support and improving its technology.

NextDC Ltd (ASX: NXT)

NextDC gives investors a very different type of technology exposure.

Rather than selling software to customers, it provides the physical data centre infrastructure needed for the digital economy to function.

That includes cloud computing, AI, cybersecurity, streaming, enterprise software, data storage, and online services. All of those activities need secure, reliable, power-hungry facilities behind them.

I think this is one of the most important technology themes on the ASX.

The digital world can look weightless from the outside, but the infrastructure behind it is very real. Companies need capacity, power, cooling, connectivity, security, and locations that support large-scale computing.

NextDC is positioned in that infrastructure layer. And if the demand outlook continues to strengthen, I think the company could have many years of growth ahead.

Foolish Takeaway

The ASX tech shares I like most are not just selling into a fashionable theme. They are becoming part of the systems, workflows, and infrastructure that customers need to operate.

That is what makes this group appealing to me. Each business has a different risk profile, and FY27 could still bring plenty of volatility. But I think specialist software, platform technology, and digital infrastructure remain powerful areas of long-term growth.

The post Which top ASX tech shares would I buy for FY27? appeared first on The Motley Fool Australia.

More reading

• Top brokers name 3 ASX shares to buy next week
• Brokers name 3 ASX shares to buy right now
• 2 incredible ASX 200 shares to buy and hold for 10 years
• 3 buy-rated ASX growth shares tipped to rise 30%+
• The ASX shares I’d pick in a FIFA World Cup first eleven

Motley Fool contributor Grace Alvino has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Netwealth Group and WiseTech Global. The Motley Fool Australia has positions in and has recommended Netwealth Group and WiseTech Global. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Qube Holdings Ltd (ASX: QUB) share price is in focus after the company announced an update on its proposed scheme of arrangement. Key highlights include confirmation of the Special Dividend and changes to the indicative timetable for the scheme.

What did Qube report?

• The Board intends to declare a fully franked Special Dividend of $0.3465 per share if the scheme becomes effective
• Scheme Meeting is scheduled for 16 June 2026
• Second Court Hearing postponed to 7 July 2026
• Proposed implementation date for the scheme is 14 August 2026
• All dates are indicative and subject to regulatory and court approvals

What else do investors need to know?

The scheme still requires key regulatory approvals, including from the ACCC, FIRB, and New Zealand’s OIO. The ACCC’s Phase 1 determination deadline is 19 June 2026, with the OIO’s decision expected in early July.

Qube will proceed with its Scheme Meetings as planned, first for general shareholders (excluding UniSuper) and then for UniSuper. The revised schedule allows time for the remaining conditions precedent to be completed or waived.

What’s next for Qube?

Looking ahead, Qube shareholders will vote on the scheme at the upcoming meetings. If approvals are secured, shareholders could receive the proposed fully franked Special Dividend, and the transaction could complete by August.

The Board continues to unanimously recommend the scheme in the absence of a superior proposal and provided the independent expert maintains a positive opinion.

Qube share price snapshot

Over the past 12 months, Qube share have risen 18%, outperforming the S&P/ASX 200 Index (ASX: XJO) which has risen 4% over the sae period.

View Original Announcement

The post Qube Holdings scheme update: Dividend and key dates revealed appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• Abacus Storage King announces June 2026 distribution
• ASX 200 rockets to a 2-month high as investors pile back in
• Elders confirms Killara Feedlot sale completion for June 2026
• Sigma Healthcare withdraws from Boots sale process

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

The post Here are the top 10 ASX 200 shares today appeared first on The Motley Fool Australia.

More reading

• Abacus Storage King announces June 2026 distribution
• ASX 200 rockets to a 2-month high as investors pile back in
• Elders confirms Killara Feedlot sale completion for June 2026
• Sigma Healthcare withdraws from Boots sale process
• Perseus Mining expands share buy-back to $150 million: June 2026 update

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Since its spin-off from Wesfarmers Ltd (ASX: WES) back in late 2018, Coles Group Ltd (ASX: COL) shares have been a popular choice for investors seeking large, stable, and fully franked dividends.

Coles ticks many, if not most, of the boxes that income investors look out for in a dividend stock. It is a mature company with an established market presence across Australia, and has carved out a defensible position as the clear second player in the grocery and supermarket sector.

That in itself is also a drawcard. As an established consumer staples stock, Coles specialises in products like food, drinks, and household essentials that we tend to need to buy. This means that Coles is inherently resistant to economic maladies like inflation and recessions.

So Coles offers up what most ASX dividend investors are looking for in an investment. But let’s get down to what kinds of income one might actually expect from buying Coles shares today.

At the time of writing, Coles is trading at $23.52 a share, down a rather potent 2.06% for the day thus far. At this price, the company is trading on a trailing dividend yield of 3.1%.

That yield comes from the last two dividends that this company has doled out. The first of those was the final dividend from September last year, worth 32 cents per share. The second, the interim dividend that shareholders bagged in March, worth 41 cents per share. As we’ve already established, both payments came with full franking credits attached.

That 12-month total of 73 cents per share gives us that 3.1% yield at the present share price.

Will Coles shares keep dividend investors happy?

But this yield is just a trailing one, and tells us only what Coles has paid out in the past, not what it might yield if one buys the shares today.

Of course, no one can predict a company’s future payouts with certainty until the company itself tells us what to expect. Coles does have a strong track record, having delivered an annual dividend pay rise every year since its ASX float. But again, that does not guarantee future rises.

Fortunately for investors, analysts are optimistic when it comes to how much the company might pay out in the years ahead.

As my Fool colleague Tristan covered earlier this month, analysts at CMC Invest are pencilling in a 12-month total of 77.7 cents per share for FY2026. That rises to 85.2 cents per share for FY2027, and then all the way to 91 cents per share in FY2028.

That would indicate forward yields of 3.3%, 3.62%, and 3.87% respectively. If accurate, this would be very good news for Coles investors indeed. Let’s see if the company measures up to these optimistic expectations.

The post Buying Coles shares? Here’s the dividend yield you’ll get today appeared first on The Motley Fool Australia.

More reading

• Why Aussie Broadband, Coles, EOS, and Santos shares are falling on Monday
• Here are the top 10 ASX 200 shares today
• 3 compelling reasons to buy the rebound in Coles shares today
• Buy, hold, sell: Coles, BHP, CBA shares
• Why Coles and Woodside shares are being tipped as buys

Motley Fool contributor Sebastian Bowen has positions in Wesfarmers. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Wesfarmers. The Motley Fool Australia has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Abacus Storage King (ASX: ASK) share price is in focus after the company declared a 3.1 cent per security distribution for the six months ending 30 June 2026. The upcoming payout includes a partially franked component, offering value for investors.

What did Abacus Storage King report?

• Distribution declared: 3.1 cents per security for the half-year ending 30 June 2026
• Franked amount: 25% (0.775 cents per security)
• Unfranked amount: 75% (2.325 cents per security)
• Ex date: 30 June 2026; Record date: 1 July 2026
• Payment date: 31 August 2026
• Dividend Reinvestment Plan (DRP) not active for this distribution

What else do investors need to know?

The dividend relates to the six-month reporting period ending 30 June 2026, with 25% franked at a 30% corporate tax rate. This means shareholders will receive franking credits on a quarter of the payment, which could benefit those in lower tax brackets.

There is no conduit foreign income component in this distribution, so only Australian-sourced franking credits and income will be received. The distribution will be paid in Australian dollars.

What’s next for Abacus Storage King?

Investors may look forward to confirmation of the ordinary dividend’s final amount, which is expected to be announced closer to the 17 August 2026 date. The company’s steady distribution policy aims to balance rewarding investors with reinvesting in its self-storage asset portfolio.

Abacus Storage King’s upcoming distribution continues its focus on supporting unitholder returns. As market conditions unfold, management’s disciplined approach should help maintain future payouts in line with company guidance.

Abacus Storage King share price snapshot

Over the past 12 months, Abacus Storage King shares have declined 8%, trailing the S&P/ASX 200 Index (ASX: XJO) which has risen 4% over the same period.

View Original Announcement

The post Abacus Storage King announces June 2026 distribution appeared first on The Motley Fool Australia.

More reading

• Here are the top 10 ASX 200 shares today
• ASX 200 rockets to a 2-month high as investors pile back in
• Elders confirms Killara Feedlot sale completion for June 2026
• Sigma Healthcare withdraws from Boots sale process
• Perseus Mining expands share buy-back to $150 million: June 2026 update

Motley Fool contributor Laura Stewart has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips. This article was prepared with the assistance of Large Language Model (LLM) tools for the initial summary of the company announcement. Any content assisted by AI is subject to our robust human-in-the-loop quality control framework, involving thorough review, substantial editing, and fact-checking by our experienced writers and editors holding appropriate credentials. The Motley Fool Australia stands behind the work of our editorial team and takes ultimate responsibility for the content published by The Motley Fool Australia.

Monash IVF Group Ltd (ASX: MVF) shares have had a tough couple of years.

Since this time in 2024, the ASX fertility stock has lost almost 50% of its value.

Does this make its shares good value today? Let’s see what Bell Potter is saying about the company and its shares.

What is the broker saying about this ASX stock?

Bell Potter notes that trading conditions remain challenging for the fertility treatment company. As a result, it was not surprised with its recent guidance downgrade. It said:

MVF’s lower guidance is not really surprising given the Medicare data that has led the way through the 10 months to April, with no sign of material improvement in May or June. MVF has lowered guidance for U.NPAT to $17m – $18m from a range of $20m to $23m previously. BP was at $20m. The c.15% downgrade reflects an environment where Australian Stimulated Cycles on a R12M basis are c.-1.9% with market conditions being quite difficult over the past two years. The fact that R3M data indicated a decline of c.-4.7% only emphasises the point.

One positive is that the ASX stock has reported improvements in its market share. It adds:

Countering this is the improvement MVF is starting to see in its market share. It is early days in the tenure of the new CEO but the 100bp improvement in market share to c.20.1% on a R3M basis indicates stabilisation of a business that has been challenged by a combination of brand issues and cost of living pressures. Indeed, the lower guidance we suggest is more about the macro settings than previous brand issues. Another bright spot is the international business that is continuing to grow and is expected to print materially higher volumes in 2H26 over pcp.

Should you invest?

According to the note, the broker thinks investors should keep their powder dry for the time being.

In response to the guidance update, Bell Potter has retained its hold rating and 75 cents price target. Based on its current share price of 71 cents, this implies only modest upside of 5.5% over the next 12 months.

Commenting on its recommendation, the broker said:

We have adjusted our earnings estimates for FY26 only at this stage to reflect the bottom of the lower guidance range, although revenue for FY27e / FY28e is rebased. MVF advise that its cost out and efficiency initiatives are underway, but implementation comes too late to impact the FY26 result.

We assume that earnings shall remain flat compared with prior estimates which implies MVF need to deliver material efficiencies and cost savings, as we expect the top line to remain challenging. A material cost out programme would be well received by the market, given undemanding multiples. We retain our $0.75 TP and HOLD recommendation.

The post Down 50%: Is this ASX stock a buy? appeared first on The Motley Fool Australia.

More reading

• Leading brokers name 3 ASX shares to buy today
• Why Accent, IperionX, Northern Star, and Sigma Healthcare shares are racing higher on Monday
• Can the DroneShield share price climb back to $6?
• How high does UBS think this ASX uranium share will go?
• Why Aussie Broadband, Coles, EOS, and Santos shares are falling on Monday

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

With lots of ASX shares to choose from on the Australian market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares that leading brokers have named as buys this week are outlined below. Here’s why they are bullish on them:

Bannerman Energy Ltd (ASX: BMN)

According to a note out of UBS, its analysts have initiated coverage on this uranium developer’s shares with a buy rating and $5.15 price target. The broker is positive on the long-term uranium outlook and is forecasting a price of US$100 per pound. This is due to an increasing focus on energy security and growing demand from AI and data centres. UBS highlights that this enhances the project economics of Bannerman’s Etango operation in Namibia, which it views as a relatively stable jurisdiction with a track record of successful and stable uranium assets with international ownership. In light of this, the broker sees significant value in the company’s shares at current levels. The Bannerman Energy share price is trading at $3.52 on Monday afternoon.

DigiCo Infrastructure REIT (ASX: DGT)

A note out of Bell Potter reveals that its analysts have retained their buy rating and $3.40 price target on this data centre operator’s shares. The broker highlights a seemingly exponential acceleration in data centre construction in recent years. In fact, it points out that this construction boom is now contributing 1.9% of Australia’s GDP. While there are many winners from this trend, the broker believes DigiCo Infrastructure REIT likely presents the most upside opportunity via acceleration of its SYD1 DC expansion. It believes this expansion will be able to capture current demand and boost EBITDA above consensus expectations. The DigiCo Infrastructure REIT share price is fetching $2.58 at the time of writing.

Seek Ltd (ASX: SEK)

Another note out of Bell Potter reveals that its analysts have retained their buy rating on this job listings company’s shares with a reduced price target of $18.60. The broker remains positive on Seek and has named the company as its preferred rate-sensitive classifieds exposure. It also highlights its belief that Seek is well-placed to avoid disruption from artificial intelligence (AI), pointing out that its underlying proprietary data (~750m points per day) partially consists of traffic meta data which is unable to be scraped by third parties. It thinks this is valuable for targeted job placements and should support yield through soft volume environments. The Seek share price is trading at $13.91 on Monday afternoon.

The post Leading brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.

More reading

• How high does UBS think this ASX uranium share will go?
• Bell Potter says this popular ASX 200 stock could deliver a 40% return
• 5 things to watch on the ASX 200 on Monday
• DigiCo Infrastructure REIT boosts liquidity via US sale and reaffirms FY26 earnings
• Are these the 3 best value ASX 200 shares right now?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The S&P/ASX 200 Index (ASX: XJO) is starting the week in style. At the time of writing, the benchmark index is up 1.35% to 8,923.7 points.

Four ASX shares that are rising more than most today are listed below. Here’s why they are storming higher:

Accent Group Ltd (ASX: AX1)

The Accent share price is up 15% to 74.5 cents. This follows news that major shareholder, Frasers Group, has made a low-ball takeover offer of 65 cents per share. This was where the footwear retailer’s shares ended last week. The company’s board has advised shareholders to take no action. It said: “The Accent Board notes that: the Offer Price is equal to the last closing price of Accent shares on 12 June 2026 and therefore represents no premium to that closing price; Frasers’ own substantial holding notice discloses that its last on-market purchases of Accent shares occurred between 3 February 2026 and 5 February 2026, at average prices above A$0.90, which is materially above the Offer Price; and because the Offer is an on-market bid, shareholders who sell their Accent shares to Frasers will not be able to withdraw that sale and will not receive the benefit of any increase in the Offer Price or any superior proposal that may emerge.”

IperionX Ltd (ASX: IPX)

The IperionX share price is up 6% to $5.43. This morning, the titanium products company announced the US$3 million acquisition of critical mineral and mining assets adjacent to its flagship Titan Project in Tennessee. Management notes that the deal consolidates its position in the Big Sandy Critical Minerals Province. It also brings together established infrastructure and large stockpiles of pre-processed rare earth minerals.

Northern Star Resources Ltd (ASX: NST)

The Northern Star share price is up 7.5% to $20.73. Investors have been buying gold miners today after the precious metal surged in response to a peace deal between the US and Iran. With oil now flowing through the Strait of Hormuz and oil prices tumbling, there are hopes that inflation could ease and interest rates may not need to rise further.

Sigma Healthcare Ltd (ASX: SIG)

The Sigma Healthcare share price is up 7% to $2.83. Investors have been buying the Chemist Warehouse owner’s shares after it announced that it was no longer interested in acquiring UK pharmacy chain Boots. It advised: “Sigma engaged in the Boots sale process given the potentially unique opportunity it presented to accelerate its UK expansion through the market-leading Boots brand and large footprint. However, following its preliminary review the Company has concluded that such an acquisition would not currently meet its strategic and capital investment objectives.”

The post Why Accent, IperionX, Northern Star, and Sigma Healthcare shares are racing higher on Monday appeared first on The Motley Fool Australia.

More reading

• Sigma Healthcare shares are surging. What does Macquarie say they’re worth?
• 3 ASX shares I’d buy that are not banks, miners, or supermarkets
• Why this ASX 300 stock is jumping 10% today?
• Sigma Healthcare withdraws from Boots sale process
• Guess which ASX stock is jumping on takeover offer

Motley Fool contributor James Mickleboro has positions in Accent Group. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Accent Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

DroneShield Ltd (ASX: DRO) shares are slipping again on Monday.

At the time of writing, the DroneShield share price is down 0.51% to $2.945 during mid-afternoon trade.

The ASX defence share has now fallen more than 56% from the record high of $6.71 reached in early October 2025.

However, DroneShield shares are still up around 74% over the past 12 months. Investors have backed rapid revenue growth and rising demand for counter-drone technology.

So, could the stock eventually make its way back above $6?

What does the chart say?

The first challenge is getting the share price back above $3.

DroneShield shares have repeatedly traded around this level over recent weeks, making it an important area for buyers and sellers.

The stock is also sitting below the middle of its 20-day Bollinger Band, which is around $3.02. The upper band is near $3.64, making that the next major resistance area if the shares begin climbing.

The 14-day relative strength index (RSI) is around 44. That puts the stock below the neutral level of 50, but it’s not yet in oversold territory.

On the downside, the lower Bollinger Band sits near $2.41. A fall towards that level would leave the share price with even more ground to recover.

Can DroneShield return to $6?

Reaching $6 would require the shares to more than double from today’s price.

That is possible, but the company will probably need more than a technical rebound.

DroneShield reported $216.5 million of revenue in 2025, up from $57.5 million a year earlier. It also entered 2026 with a growing international presence and continued demand from defence customers.

The company has since announced a US$24.9 million contract linked to the US Department of War. It had also secured $155 million of committed 2026 revenue by 20 April.

However, sentiment has been held back by an ASIC investigation covering company announcements and share trading during November 2025. DroneShield has said it will cooperate fully, but the uncertainty may continue to weigh on the stock.

Broker opinions are also divided. Recent price targets have ranged from $2.28 to $4.80, with even the most optimistic target still below $6.

What would need to happen?

A move above $3.60 would be an encouraging start, followed by a break through the $4 to $4.80 area.

From there, investors would need to see more major contract wins, and stronger profits to justify another push towards the record high.

DroneShield has already shown how quickly it can move when sentiment improves. But with the shares still trading below several resistance levels, $6 looks like a long-term target.

The post Can the DroneShield share price climb back to $6? appeared first on The Motley Fool Australia.

More reading

• 3 ASX shares I’d buy that are not banks, miners, or supermarkets
• DroneShield’s big European news fails to halt share price slide
• Here are the 10 most shorted ASX shares
• ASX defence shares like Droneshield have soared since 2022. Is there any growth left?
• 3 reasons to buy DroneShield shares in June

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.